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590Clinical Outcomes of Descemet Membrane
Endothelial Keratoplasty Using Eye
Bank–Prepared TissuesSOPHIE X. DENG, P. JAMES SANCHEZ, AND LUXIA CHEN PURPOSE: To investigate the outcomes of Descemet
membrane endothelial keratoplasty (DMEK) using
prestripped donor tissue prepared by an eye bank.
 DESIGN: Retrospective, noncomparative case series.
 METHODS: This retrospective, noncomparative,
observational study investigated the outcomes of the
first 40 consecutive DMEK procedures performed by
a single surgeon using prestripped tissues prepared by
a single eye bank during the period September 17,
2013 to July 1, 2014. A new technique to unfold the
Descemet membrane grafts using a single cannula was
described. Medical records were reviewed to obtain
the prestripped and poststripped endothelial cell counts
(ECC), postoperative ECC, visual acuity measure-
ments, and complications.
 RESULTS: Of the 43 prestripped tissues received, 40
were transplanted. The leading indications for DMEK
were Fuchs endothelial corneal dystrophy (n [ 28) and
bullous keratopathy (n [ 11). Nine DMEK procedures
were performed in combination with phacoemulsification
and posterior chamber intraocular lens implantation. Six
patients had undergone prior glaucoma surgeries. The
mean follow-up duration was 5.3 months (range,
1 week to 11 months). Preoperative spectacle-corrected
visual acuity was £20/200 in 8 patients (20%) and
£20/40 in 37 patients (92.5%). Primary graft failure
occurred in the first case. Thirty-eight patients had
improved vision postoperatively. Among the 39 patients
who had successful DMEK, postoperative BCVA was
‡20/20 in 20 patients (51.2%), ‡20/25 in 30 patients
(76.9%), and ‡20/40 in 34 patients (87.2%) by the
last follow-up. There was no secondary graft failure.
Rejection occurred in 2 patients because of self-
discontinuation of topical corticosteroid. The most
common complication was partial detachment requiring
air injection (11 of 40 patients; 27.5%). Mean ECCupplemental Material available at AJO.com.
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PUBLISHED BY Eloss after stripping of Descemet membrane was 3.9%
(range, 6.5% gain to 14.5% loss). During the first
6 months after transplantation, the average ECC loss
was 30.5% (range, 3.8%–67.4% loss).
 CONCLUSIONS: DMEK using eye bank–prepared tissue
achieved outcomes comparable to those reported for
DMEK using surgeon-prepared tissue. (Am J
Ophthalmol 2015;159:590–596. Published by Elsevier
Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).)
D
ESCEMET MEMBRANE ENDOTHELIAL KERATO-
plasty (DMEK) offers better and faster visual
rehabilitation and a lower risk of immune
rejection than Descemet stripping endothelial keratoplasty
(DSEK) and penetrating keratoplasty.1–5 It is replacing
DSEK and becoming the preferred procedure for the
treatment of endothelial dysfunction.6,7 However,
obstacles in performing DMEK remain. DMEK is more
technically difficult than DSEK, and it has a steeper
learning curve.8–10 The success rate has increased
drastically with the improvement of the surgical
technique since the first report of DMEK in 2006.11
Many cornea surgeons have not started performing
DMEK because of the challenge of donor preparation.
If the stripping of the DMEK tissue is unsuccessful,
it leads to tissue wastage and cancellation of the
surgery.
Currently, an increasing number of eye banks in the
United States have started to prepare prestripped
DMEK donor tissues, but there is little published infor-
mation about surgeon preference and factors that may
affect the success and clinical outcome of DMEK.
Prestripped tissues stored up to 2 days have been shown
to achieve a clinical outcome similar to freshly stripped
tissues.12 If tissues that are prestripped by an eye bank
are proven to be as reliable and have the same quality
as those prepared by the surgeons, eye bank–prepared tis-
sues could help make DMEK more accessible to all
cornea surgeons.
In the current study, we retrospectively evaluated the
clinical outcomes of DMEK using tissues prepared by an
eye bank. A new technique of unfolding the donor tissue
is also described.0002-9394/$36.00
http://dx.doi.org/10.1016/j.ajo.2014.12.007
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METHODS
THIS RETROSPECTIVE, NONCOMPARATIVE STUDY EVALU-
ated the first 40 consecutive DMEK procedures using tis-
sues prestripped by an eye bank (Sightlife International,
Seattle, Washington, USA). All DMEK procedures were
performed at the Jules Stein Eye Institute, University of
California, Los Angeles, during the period September 17,
2013 to July 1, 2014. The study was approved by the Insti-
tutional Review Board, and DMEK was performed in all
cases by 1 surgeon (S.X.D.). Information collected from
each patient’s medical record included indication for sur-
gery, other ocular diagnoses, preoperative best-corrected
Snellen visual acuity (BCVA), prestripped endothelial
cell count (ECC), poststripped ECC, postoperative ECC,
preoperative manifest refraction, postoperative manifest
refraction, and complication type and rate. Prestripped
and poststripped ECC were obtained from the eye bank.
Postoperative ECC were obtained by specular microscopy
(Konan Medical, Irvine, California, USA).
 GRAFT PREPARATION: On the day before surgery, the
eye bank technician manually stripped the Descemet mem-
brane (DM) from the posterior stroma of the donor graft us-
ing the SCUBA technique,13 leaving a small portion of the
DM-stromal adhesions intact at the periphery. The donor
tissues had been previously stored in Optisol solution at
48C. The prestripped donor cornea was again stored in
Optisol solution and shipped in a container with a viewing
chamber (Krolman Corp, Boston, Massachusetts, USA) at
48C to the Jules Stein Eye Institute for next-day surgery.
 SURGERY: All surgeries were performed under moni-
tored anesthesia care and retrobulbar block. The prestrip-
ped donor DM graft was further prepared as shown in
Figure 1. The corneal button was secured on a vacuum
donor punch block. The edge of the donor DM was visual-
ized by staining with 0.06% trypan blue dye (VisionBlue;
Duch Ophthalmic, Exeter, New Hampshire, USA). If a
small tear was present at the periphery, the graft was
slightly decentered to avoid the torn area. An 8.0- to
8.75-mm trephine was used to create a partial-thickness
cut. The size of the graft was determined by the size of
the recipient cornea to allow a 1.5- to 2.0-mm space be-
tween the graft and the limbus. The rim of the DM was
removed, and the inner trephined DM tissue was
completely detached from the stroma by using 2 pairs of
smooth tying forceps to grasp the edge of the DM. The
DM was held by 1 pair of tying forceps and submerged in
trypan blue dye for 15 seconds; subsequently, the DM was
placed in balanced salt solution (BSS; Alcon, Ft Worth,
Texas, USA) in a glass dish while the DM of the recipient
was stripped.
If the surgery was a combined DMEK and cataract sur-
gery, the cataract was removed by phacoemulsification.VOL. 159, NO. 3 OUTCOME OF EYE BANK–PREPARED DEThe intraocular lens was implanted after DM was removed
from the host. DM was stripped using a reverse Sinskey
hook under viscoelastic (Healon; Abbott, Santa Ana,
California, USA). The size of descemetorrhexis was the
same as that of the graft. Two small peripheral iridectomies
were made at 6 and 12 o’clock by straight intraocular
microsurgical scissors (MicroSurgical Technology,
Redmond, Washington, USA). A 2.4 mm (for Viscoject)
or 3.0 mm (for Staar injector) temporal clear corneal inci-
sion was then made and viscoelastic was removed from the
anterior chamber. Acetylcholine (Miochol; Bausch and
Lomb, Bridgewater, New Jersey, USA) was injected intra-
camerally to induce miosis.
The edge of the DM graft was grasped with a pair of tying
forceps, and the DM graft was placed in trypan blue for
another 15 seconds and then back in BSS. A double scroll
could be formed by gentle shaking of the DM in BSS as
shown in Figure 1 (Middle right); this configuration facili-
tated unfolding of the DM scroll. The double-scroll DM
was loaded into an injector (Staar Surgical, Monrovia,
California, USA, or Viscoject; Medicel, Wolfhalden,
Switzerland) with special attention to the removal of all
air bubbles from the injector and cartridge. The graft was
injected into the anterior chamber through the temporal
incision and rotated during the insertion to keep the double
scroll in an upward-facing position.
The donor graft was unfolded using a ‘‘touch, no touch’’
technique in which a 30 gauge cannula was used to unfold
the DM scroll on the DM side without touching the endo-
thelium (Figure 2, and Supplemental Video, available at
AJO.com). The cannula was inserted into the DM scroll.
The tip of the cannula gently pushed the wall of the DM
scroll in a circular outward motion. A combination of
gentle stroking of the cornea, a small air bubble, and small
spurs of BSS were used if necessary to completely unfold
the DM graft. Once the DM graft was unfolded and
centered, air was injected under the graft to attach it to
the recipient stroma and to completely fill the anterior
chamber for 10 minutes. At the end of this period, air
was released to achieve a physiologic IOP <20 mm Hg
while leaving the anterior chamber 90% air-filled. All pa-
tients received subconjunctival injections of dexametha-
sone and cefazolin. Vancomycin was used in patients
who were allergic to cephalosporins. All patients were
instructed to stay in a supine position in the recovery
room for 1–2 hours, and then returned to the operating
room to confirm proper positioning of the graft. If the
IOP was judged to be higher than a physiologic pressure
by digital palpation, a small amount of air was released
from the anterior chamber. The patient was instructed
to stay in the supine position overnight.
Postoperative air injection was performed under aseptic
conditions in the minor procedure room if the patient
had visually significant graft edema or symptoms of corneal
edema within the first 4 weeks after surgery.591SCEMET MEMBRANE DONOR TISSUES
FIGURE 1. Steps of preparing prestripped cornea tissues from eye bank for Descement membrane (DM) endothelial keratoplasty
before transplantation. The tissue was inspected prior to surgery in the shipping container (Top left). The tissue was secured on a
vacuum donor punch block, and trypan blue dye was added to visualize the edge of the DM (arrow, Top center). After trephination,
the rim of the DM was removed (Top right), and the center portion of the DM was completely removed from the stroma using a
bimanual maneuver (Middle left). A single-scroll DM (Middle center) was gently moved from side to side in balanced salt solution
(Middle right) to form a double scroll (Bottom left). The double-scroll DM was loaded into an injector (Bottom center), and the
DM was injected into the anterior chamber with the double scroll facing up (Bottom right).RESULTS
ATOTALOF 43 PRESTRIPPEDTISSUESWERERECEIVED,AND40
were transplanted during the review period. The average
age of the donors was 61 years (range, 52–73 years). The
average time from donor death to surgery was 4 days (range,
2–7 days). All tissues were stripped at the eye bank and
shipped in a cornea storage container with a viewing cham-
ber the day before surgery (Figure 1, Top left). The viewing
chamber permitted stabilization of corneal tissues during
shipping. Prior to surgery, all tissues were grossly inspected
for stromal opacity and presence of large folds in the DM.
Except for 1 donor tissue, all stripped DM remained flat
on the stromal bed, undisturbed by the shipping process.
In the exception, the edge of the tissue scrolled under the
remaining stripped DM. This scrolling was attributable to
a 2- to 3-mm tear at the periphery. The scroll was unfolded592 AMERICAN JOURNAL OFand flattened successfully to permit trephination, which
was slightly off center to avoid the peripheral tear. The
edge of the stripped DM was found to be at the junction
with the trabecular meshwork (Figure 1, Top center) in
most tissues.
Three tissues were not transplanted. One was not used
because of a tear in the central DM during the final prepa-
ration. The central portion of the DM was not peeled and
was still tightly adhered to the stroma. A break occurred in
the center of the DM during final peeling using a bimanual
maneuver.14 The second tissue was not used owing to a low
cell count after stripping. In the third case, the surgery was
converted to DSEK. This patient had previous vitrectomy
and glaucoma shunt implantation that complicated the
DMEK procedure.
The average age of recipients was 72 years (range, 51–93
years). Seventeen patients were male (44%). The medianMARCH 2015OPHTHALMOLOGY
FIGURE 2. ‘‘Touch, no touch’’ technique of unfolding the Descemet membrane (DM) graft using a single cannula during Descemet
membrane endothelial keratoplasty.When the DM graft is in a single-scroll conformation, a 30 gauge cannula is inserted in the center
(Top left). A small air bubble is injected to unfold the single scroll (Top center). The partially opened scroll is unfolded manually
using a single cannula in the interface between the DM graft and the recipient cornea without touching the endothelium directly
(Top right). If the DM is in a double-scroll conformation, the cannula is inserted into 1 of the scrolls to unfold the DM graft on
that side first, followed by unfolding the other side (Bottom left). The DM graft is centered using the cannula (Bottom center)
and unfolded completely in the interface (Bottom right) before injection of air under the graft.size of the DM grafts was 8.25 mm (range, 7.75–8.75 mm).
The indications for DMEK in the 40 patients were Fuchs
endothelial corneal dystrophy (n ¼ 28; 70%), bullous
keratopathy (n ¼ 11; 27.5%), and failed DMEK graft
from outside facility (n ¼ 1; 2.5%). Potential vision-
limiting factors included corneal scar (9 patients), glau-
coma (7 patients), age-related macular degeneration (3 pa-
tients), and cystoid macular edema (2 patients).
The mean follow-up time was 5.3 months (range, 1 week
to 11 months). Thirty-one DMEK were performed as a sin-
gle procedure, 9 as a combined procedure with cataract
extraction and posterior intraocular lens implantation, 1
with pars plana vitrectomy, and 1 with amniotic patch graft
removal. Four patients had previously undergone trabecu-
lectomy and 2 had both trabeculectomy and glaucoma
shunt implantation.
Thirty-nine of the 40 DMEK grafts cleared. One patient
(2.5%) had primary graft failure and subsequently under-
went successful DSEK. Preoperative spectacle-corrected vi-
sual acuity was <_20/200 in 8 patients (20.0%) and <_20/40 in
37 patients (92.5%). Thirty-eight of the 39 patients who
had successful DMEK had improved vision. The vision ofVOL. 159, NO. 3 OUTCOME OF EYE BANK–PREPARED DE1 patient remained at hand motion owing to end-stage
glaucoma. By postoperative month 1, corrected visual acu-
ity was >_20/20 in 9 patients (23.1%), >_20/25 in 18 patients
(46.2%), and >_20/40 in 26 patients (66.7%). By the time of
last follow-up, corrected visual acuity >_20/20 was achieved
in 20 patients (51.1%), >_20/25 in 30 patients (76.9%), and
>_20/40 in 34 patients (87.2%). The median VA was 20/20
(range, 20/20 to hand motion). The number of eyes reach-
ing each BCVA level by the time of last follow-up is shown
in Figure 3.
The prestripped and poststripped ECC were recorded for
all 40 DM tissues. The mean prestripped ECC was 3032 6
204 cells/mm2, and the mean poststripped ECCwas 29146
231 cells/mm2. The mean endothelial cell loss after strip-
ping was 3.8% (range, 15% loss to 10% gain). Postoperative
ECC was recorded in 67.5% of patients (27/39) within the
first 6-month postoperative period. The mean poststripped
ECC of the DM tissues used in these 27 patients was 2878
6 212 cells/mm2, and the mean postoperative ECC was
1997 6 463 cells/mm2. This represents an overall cell
loss of 30.5% (range, 3.8%–67.4% loss) within the first
6-month postoperative period.593SCEMET MEMBRANE DONOR TISSUES
FIGURE 3. Visual acuities before and after successful Descemet membrane endothelial keratoplasty. Visual acuity results are cate-
gorized by the percentage achieving each visual acuity level (Left) and by number of eyes (Right) by the time of last follow-up. Pre-op,
preoperative; Post-op, postoperative.Because ECC was measured at different times during the
postoperative period (range, 1 week to 11 months) and
more than once in 11 patients, we next analyzed the
ECC recorded at different times during the postoperative
period. The average endothelial cell loss was 29.4% 6
12.2% (n ¼ 13) at 1 month, 30.9% 6 17.6% (n ¼ 18) at
3 months, 23.4% 6 13.4% (n ¼ 8) at 6 months, and
9.2% 6 24.3% (n ¼ 3) at 10 months.
Preoperative and postoperative manifest refraction was
recorded for 28 patients during the first 3 months after sur-
gery. The mean preoperative spherical equivalent
was 0.46 diopter (D), and the mean postoperative spher-
ical equivalent wasþ0.06 D; therefore, themean hyperopic
shift was 0.51 D (range, 1.38 to þ2.50 D).
The most common complication was partial detach-
ment of the DM graft at the periphery. Air injection
was performed in 11 of the 40 patients (27.5%) to facili-
tate visual recovery. No total detachment or upside-down
graft occurred. A single air injection was sufficient for
reattachment in 10 of the 11 patients (90.9%). One pa-
tient required 2 air injections. This patient was not
compliant and did not stay in a supine position after
the initial DMEK and the first air injection. None of
the 6 patients who had undergone prior trabeculectomy
or glaucoma shunt required air injection. The average
time of air injection was 15 days after surgery (range, 4–
36 days).
Primary graft failure was observed in the first DMEK
attempted (2.5%). This case was complicated by anatom-
ically narrow angles and the patient developed aqueous
misdirection intraoperatively requiring pars plana vitrec-
tomy prior to insertion of the DM graft. Partial detach-
ment of the DM graft occurred and corneal edema
persisted after refloat. The patient eventually underwent
successful DSEK 26 days later and achieved 20/20 at
1 month after DSEK. No secondary graft failure occurred
during the study period. Immunologic rejection was594 AMERICAN JOURNAL OFobserved in 2 patients who self-discontinued topical corti-
costeroid therapy 2 months after surgery. Both patients
presented with only a couple of small keratoprecipitates
on the endothelium without corneal edema or decreased
vision. Restarting topical 1% prednisolone acetate 4 times
daily successfully reversed rejection.DISCUSSION
THE CURRENT STUDY SHOWS THAT CLINICAL OUTCOMES
of DMEK using prestripped donor tissues prepared by an
eye bank are comparable to those of DMEK in which tissues
are prepared by surgeons. Within 3 months after surgery,
92% of patients achieved a BCVA of >_20/40, and 63%
achieved a BCVA of >_20/25. These visual outcomes are
comparable to those recently reported in the literature
with surgeon-stripped donor tissues.3,15–19 The graft
rejection rate of 5.1% in this study does not reflect the
true rejection rate, as both patients self-stopped topical
corticosteroid therapy during the early postoperative period.
Partial detachment was the most common complication
in the current study. This complication was managed suc-
cessfully with a single air injection into the anterior cham-
ber to facilitate visual recovery in 10 of the 11 patients who
required air injection. The reported rates of partial detach-
ment of surgeon-prepared DMEK tissues that required air
injection range from 9% to 82%.6,13,17 Often, small
detachment at the periphery does not affect final visual
acuity and could reattach spontaneously. Air injections
were performed in 3 patients who wished to have faster
visual recovery or symptomatic relief from local corneal
edema despite >_20/40 vision. The air injection rate in the
current study is well within the published range. In
addition, none of the eyes that had previous glaucoma
surgery required air injection or required additionalMARCH 2015OPHTHALMOLOGY
glaucoma surgery in the current series. There is a higher
postoperative rate of complications such as graft failure in
patients with a history of previous glaucoma surgery after
DSEK.20,21 A larger study is needed to investigate
whether there is a difference in DMEK outcomes in
patients with previous glaucoma surgery.
The mean poststripped cell loss in the current study was
only 3.8%; however, the range was relatively large, from
15% loss to 10% gain. This range likely reflects a variation
of ECC at different locations. Nevertheless, our results sug-
gest that endothelial cell loss could result from manipula-
tion of DM during stripping and that this cell loss in
DMEK grafts prepared by an eye bank is within acceptable
limits. Additional endothelial cell loss occurs during trans-
plantation. The average endothelial cell loss has been re-
ported to be 31%–36%,15,19 and endothelial cell loss in
the current series is well within this range. As most ECC
in our series were obtained during the first 6 months of
the follow-up period, this loss likely resulted from the sur-
gery, as previously reported.4
DMEK is technically demanding because the delicate
thin donor tissues tend to fold into a tight scroll. Many
techniques have been described to facilitate the unfold-
ing of the DM scroll. Here we describe a new technique
to unfold the DM scroll: a single 30 gauge cannula is
inserted into the center of the scroll and is used to manu-
ally unfold the DM tissue without directly touching the
endothelium. An advantage of this technique is that
the orientation of the DM tissue is readily confirmed by
using the Moutsouris sign22 while the graft is being
unfolded. A flipped or upside-down graft is prevented us-
ing this new technique. Because the endothelium is not
touched by any instrument and there is little pressure
exerted on the DM, there might be less endothelial cell
damage. In addition, because of the variation in tissue
elasticity, use of corneas from older donors is preferred.
It has been reported that donors aged >65 years had a
greater graft stiffness, which facilitates the unfolding
process.23 A few techniques have been developed to
successfully unfold the DM grafts and reduce the need
for air injection.14,24–26 These techniques include
elimination of viscoelastic, use of SF6, and oversizing
the descemetorrhexis of the recipients.3,7,26,27 Often, a
combination of surgical techniques to efficiently unfold
the DM scroll is necessary, particularly in eyes withVOL. 159, NO. 3 OUTCOME OF EYE BANK–PREPARED DEaltered anatomy, such as those that have undergone
previous glaucoma surgeries.
Stripping the donor DM is another significant barrier to
many surgeons. Preparing the donor tissue for DSEK was
once an obstacle for many surgeons in the past because of
the lack of equipment or the same fear of damaging the
donor tissue during preparation. After eye banks started
to offer precut donor tissues for DSEK in the mid-2000s,
the number of surgeons performing DSEK increased sub-
stantially. The availability of high-quality, eye bank–pre-
pared tissues for DSEK played a pivotal role in
establishing DSEK as the treatment of choice for endothe-
lial dysfunction during that time.
Our finding suggests that stripping of DM 1 day prior to
surgery and transportation of the tissues do not appear to
affect the viability of the endothelial cells. Prestripped
DMEK tissue has been shown to have stable ECC for as
long as 4 weeks after preparation when the tissue is stored
in organ culture medium at 34 C.28 In addition, our study
confirms an earlier finding that the clinical outcome ap-
pears to be the same when the tissues are prepared and
stored at 4 C for as long as 2 days prior to surgery.12 Our
study also shows that the shipping process does not disturb
the prestripped DM. The prestripped tissues are now avail-
able from multiple eye banks in the United States. Access
to high-quality, prestripped DMEK tissue will remove a ma-
jor barrier and offer an excellent alternative for many sur-
geons who are interested in offering DMEK to their
patients. Another potential advantage of eye bank–
prepared DM tissues is that they might have greater consis-
tency than those prepared by surgeons who do not routinely
prepare the tissues.
There are several limitations to the current study. First,
this study was a small retrospective evaluation of only 40
patients. Second, the follow-up period was relatively short.
Therefore, the ECC and BCVA were not obtained at
predetermined times, and the results reflect the short-
term outcome. Third, the current series was from a single
center. A larger series of patients treated by different sur-
geons at multiple centers would be necessary to further
evaluate the overall outcome of DMEK using eye bank–
prepared tissues.
In summary, our study shows that use of eye bank–
prepared DMEK tissues achieved outcomes comparable to
those reported for surgeon-prepared DMEK tissues.ALL AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
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